| Type I and III procollagen propeptides in sarcoidosis, fibrosing alveolitis and asbestos-related lung diseases | ||
|---|---|---|
| Prev | Next | |
This thesis is based on the following articles, which are cited in the text using the Roman numerals I-IV:
I Lammi L, Kinnula V, Lähde S, Risteli J, Pääkkö P, Lakari E & Ryhänen L (1997) Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Eur Respir J 10: 2725-2730.
II Lammi L, Ryhänen L, Lakari E, Risteli J, Pääkkö P, Kahlos K, Lähde S & Kinnula V (1999) Type III and type I procollagen markers in fibrosing alveolitis. Am J Respir Crit Care Med 159:818-823.
III Lammi L, Ryhänen L, Lakari E, Risteli J, Pääkkö P, Ruotsalainen EM, Lähde S & Kinnula VL (1999) Carboxyterminal propeptide of type I procollagen is elevated in the epithelial lining fluid in asbestosis, but not in asbestos related pleural plaque disease. Eur Respir J (in press).
IV Kaarteenaho-Wiik R, Lammi L, Lakari E, Kinnula V, Risteli J, Ryhänen L & Pääkkö P (1999) Type I and III procollagens and pN-collagens are differentially distributed in usual interstitial pneumonia and sarcoidosis. (submitted for publication).